<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Hematol</journal-id>
      <journal-title-group>
        <journal-title>Annals of Hematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0939-5555</issn>
      <issn pub-type="epub">1432-0584</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21331592</article-id>
      <article-id pub-id-type="pmc">3187851</article-id>
      <article-id pub-id-type="publisher-id">1182</article-id>
      <article-id pub-id-type="doi">10.1007/s00277-011-1182-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Intracranial hemorrhage after high-dose methylprednisolone in a child with acute immune thrombocytopenic purpura</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Heitink-Poll&#xE9;</surname>
            <given-names>Katja M. J.</given-names>
          </name>
          <address>
            <phone>+31-88-7554339</phone>
            <fax>+31-88-7555350</fax>
            <email>kheitink@umcutrecht.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pot</surname>
            <given-names>Dirk Jan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Engelkes</surname>
            <given-names>Marjolein</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bruin</surname>
            <given-names>Marrie C. A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Pediatric Hematology-Oncology, University Medical Center Utrecht/Wilhelmina Children&#x2019;s Hospital, KC 03.063.0, Postbox 85090, 3508 AB Utrecht, The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Department of Pediatrics, Gelre Ziekenhuizen, Apeldoorn, The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>2</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>18</day>
        <month>2</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2011</year>
      </pub-date>
      <volume>90</volume>
      <issue>11</issue>
      <fpage>1361</fpage>
      <lpage>1363</lpage>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>8</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>2</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2011</copyright-statement>
      </permissions>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2011</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>Severe hemorrhage in children with immune thrombocytopenic purpura (ITP) is rare and occurs in 3% of patients [<xref ref-type="bibr" rid="CR1">1</xref>]. Intracranial hemorrhage (ICH), the most feared bleeding complication, has an estimated incidence of 0.1&#x2013;0.5% [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>]. Mortality rate of ICH is high and varies from 24&#x2013;57% [<xref ref-type="bibr" rid="CR2">2</xref>&#x2013;<xref ref-type="bibr" rid="CR4">4</xref>]. We report a patient with acute ITP who developed fatal ICH shortly after starting high-dose methylprednisolone.</p>
    <p>A 5-year-old girl with an unremarkable medical and family history presented to her pediatrician with acute onset of bruising and petechiae. Physical examination revealed no other abnormalities. Blood pressure was 112/60&#xA0;mmHg. Laboratory studies showed an isolated trombocytopenia of 1&#x2009;&#xD7;&#x2009;10<sup>9</sup>/L (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). She was diagnosed with acute ITP and managed conservatively. Four days after presentation, she developed large ecchymoses and epistaxis causing anemia. Intravenous immunoglobulins (IVIg; 0.8&#xA0;g/kg once) and packed red cells were administered (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Platelet count remained low (1&#x2009;&#xD7;&#x2009;10<sup>9</sup>/L) and mucosal bleeding continued. The girl was referred to our department for further management. We saw a pale, tachycardic girl with multiple ecchymoses and active mucosal bleeding from nose and mouth. Hemoglobin was 7.4&#xA0;g/dL and platelet count 2&#x2009;&#xD7;&#x2009;10<sup>9</sup>/L. After a second gift of IVIg, prednisone 2&#xA0;mg/kg/day, an erythrocyte transfusion and a large dose of platelets (ten donor units), platelet count rose to 21&#x2009;&#xD7;&#x2009;10<sup>9</sup>/L, hemoglobin stabilized and the clinical condition of our patient improved dramatically. However, 36&#xA0;h later, profuse mucosal bleeding from nose and mouth recurred at a platelet count of 1&#x2009;&#xD7;&#x2009;10<sup>9</sup>/L. We started high-dose methylprednisolone (15&#xA0;mg/kg) together with another platelet transfusion. Shortly after starting the methylprednisolone infusion, she complained of severe headache and instantly developed generalized seizures. Blood pressure at that moment was elevated: 170/90&#xA0;mmHg. Computed tomography (CT) showed extensive bifrontal ICH. Unfortunately, our patient died of progressive herniation caused by massive cerebral edema, despite continuous platelet transfusions and intensive care management. Autopsy was not performed.
<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Results of laboratory studies in our patient</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Diagnosis</th><th>Day&#xA0;4</th><th>Day&#xA0;5</th><th>Day&#xA0;6</th><th>Day&#xA0;7</th><th>Day&#xA0;8</th><th>Day&#xA0;9 (1&#xA0;h after ICH)</th><th>Day&#xA0;9 (5&#xA0;h after ICH)</th><th>Day&#xA0;10 (at moment of herniation)</th><th>Units</th></tr></thead><tbody><tr><td>Hemoglobin</td><td char="." align="char">11.6</td><td char="." align="char">5.8</td><td char="." align="char">11.3</td><td char="." align="char" rowspan="2">7.4</td><td char="." align="char">8.6</td><td char="." align="char">10.6</td><td char="." align="char">9.0</td><td char="." align="char">6.4</td><td rowspan="2"/><td>g/dL</td></tr><tr><td>Hematocrit</td><td char="." align="char">0.32</td><td char="." align="char">0.17</td><td char="." align="char">0.32</td><td char="." align="char">0.23</td><td char="." align="char">0.28</td><td char="." align="char">0.24</td><td char="." align="char">0.17</td><td>L/L</td></tr><tr><td>Platelets</td><td char="." align="char">1</td><td char="." align="char">1</td><td char="." align="char">1</td><td char="." align="char">2</td><td char="." align="char">21</td><td char="." align="char">1</td><td char="." align="char">3</td><td char="." align="char">129</td><td char="." align="char">16</td><td>&#xD7;10<sup>9</sup>/L</td></tr><tr><td>Leukocytes</td><td char="." align="char">12.7</td><td char="." align="char">7.5</td><td char="." align="char">10.6</td><td char="." align="char">14.0</td><td char="." align="char">12.6</td><td char="." align="char">15.6</td><td char="." align="char">25.1</td><td colspan="2"/><td>&#xD7;10<sup>9</sup>/L</td></tr><tr><td>Neutrophils</td><td char="." align="char">8.9</td><td char="." align="char">5.4</td><td char="." align="char">5.3</td><td colspan="6"/><td>&#xD7;10<sup>9</sup>/L</td></tr><tr><td>Lymphocytes</td><td char="." align="char">2.8</td><td char="." align="char">1.9</td><td char="." align="char">3.9</td><td colspan="6"/><td>&#xD7;10<sup>9</sup>/L</td></tr><tr><td>Activated partial thromboplastin time (APTT)</td><td char="." align="char" colspan="3">29</td><td char="." align="char" colspan="4">29</td><td char="." align="char" colspan="2">24</td><td>s</td></tr><tr><td>Prothrombin time (PT)</td><td char="." align="char" colspan="3">12.7</td><td char="." align="char" colspan="4">14.4</td><td char="." align="char" colspan="2">&lt;10</td><td>s</td></tr><tr><td>Coombs test</td><td/><td colspan="2">Negative</td><td colspan="7">Negative</td></tr></tbody></table><table-wrap-foot><p><italic>ICH</italic> Intracranial hemorrhage</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Overview of platelet counts and interventions in our patient. <italic>i</italic>&#x2009;=&#x2009;IVIg; <italic>white bar</italic> = prednisone 2&#xA0;mg/kg/day; <italic>white arrow</italic> = high-dose methylprednisolone infusion; <italic>black circle</italic> = platelet transfusion; <italic>black diamond</italic> = erythrocyte transfusion. <italic>Lightning flash</italic> = event: the first one represents onset of ICH, the second one brain herniation</p></caption><graphic xlink:href="277_2011_1182_Fig1_HTML" id="MO1"/></fig></p>
    <p>The main reason for clinicians to treat children with acute ITP and minor bleeding symptoms is to raise platelet counts in order to prevent severe bleeding complications and in particular ICH. The question is whether treatment really prevents these bleeding complications. The majority of children with severe bleeding or ICH described in literature developed these complications despite prior therapy [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR5">5</xref>]. Why do some patients develop ICH despite therapy? Apart from known risk factors like head trauma, use of non-steroidal anti-inflammatory drugs, intracranial arteriovenous malformation, and bleeding beyond petechiae and ecchymoses [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>], there are some other possible explanations. Patients may suffer from refractory ITP and remain severely thrombocytopenic despite therapy, leaving them at risk for bleeding complications [<xref ref-type="bibr" rid="CR6">6</xref>]. However, there is also a possibility of either causing or worsening ICH due to adverse effects of drug therapy. In our patient, the temporal relationship between starting methylprednisolone and development of headache and ICH remains remarkable. A sudden rise in blood pressure, a known adverse effect of high-dose methylprednisolone, could have initiated or worsened ICH.</p>
    <p>In conclusion, this report shows that treatment of ITP cannot always prevent ICH and may even be involved in initiating or worsening ICH.</p>
  </body>
  <back>
    <ack>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neunert</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Buchanan</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Imbach</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bolton-Maggs</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Neufeld</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Vesely</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Adix</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Blanchette</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Kuhne</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura</article-title>
          <source>Blood</source>
          <year>2008</year>
          <volume>112</volume>
          <fpage>4003</fpage>
          <lpage>4008</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2008-03-138487</pub-id>
          <pub-id pub-id-type="pmid">18698007</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lilleyman</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology</article-title>
          <source>Arch Dis Child</source>
          <year>1994</year>
          <volume>71</volume>
          <fpage>251</fpage>
          <lpage>253</lpage>
          <pub-id pub-id-type="doi">10.1136/adc.71.3.251</pub-id>
          <pub-id pub-id-type="pmid">7979501</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Psaila</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Petrovic</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Page</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Menell</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schonholz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bussel</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases</article-title>
          <source>Blood</source>
          <year>2009</year>
          <volume>114</volume>
          <fpage>4777</fpage>
          <lpage>4783</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2009-04-215525</pub-id>
          <pub-id pub-id-type="pmid">19767509</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choudhary</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Naithani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mahapatra</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mishra</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Saxena</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Intracranial hemorrhage in childhood immune thrombocytopenic purpura</article-title>
          <source>Pediatr Blood Cancer</source>
          <year>2009</year>
          <volume>52</volume>
          <fpage>529</fpage>
          <lpage>531</lpage>
          <pub-id pub-id-type="doi">10.1002/pbc.21728</pub-id>
          <pub-id pub-id-type="pmid">19058201</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iyori</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bessho</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ookawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Konishi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shirahata</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Miyazaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fujisawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Akatsuka</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Intracranial hemorrhage in children with immune thrombocytopenic purpura. Japanese Study Group on childhood ITP</article-title>
          <source>Ann Hematol</source>
          <year>2000</year>
          <volume>79</volume>
          <fpage>691</fpage>
          <lpage>695</lpage>
          <pub-id pub-id-type="doi">10.1007/s002770000219</pub-id>
          <pub-id pub-id-type="pmid">11195007</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Medeiros</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Buchanan</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome</article-title>
          <source>J Pediatr</source>
          <year>1998</year>
          <volume>133</volume>
          <fpage>334</fpage>
          <lpage>339</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-3476(98)70265-3</pub-id>
          <pub-id pub-id-type="pmid">9738712</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
